rs16926021

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_015634.4(KIFBP):​c.1023G>A​(p.Gln341Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,613,426 control chromosomes in the GnomAD database, including 1,459 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 761 hom., cov: 32)
Exomes 𝑓: 0.0056 ( 698 hom. )

Consequence

KIFBP
NM_015634.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.113

Publications

4 publications found
Variant links:
Genes affected
KIFBP (HGNC:23419): (kinesin family binding protein) This gene encodes a kinesin family member 1 binding protein that is characterized by two tetratrico peptide repeats. The encoded protein localizes to the mitochondria and may be involved in regulating transport of the mitochondria. Mutations in this gene are associated with Goldberg-Shprintzen megacolon syndrome. [provided by RefSeq, Mar 2010]
KIFBP Gene-Disease associations (from GenCC):
  • Goldberg-Shprintzen syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 10-69015573-G-A is Benign according to our data. Variant chr10-69015573-G-A is described in ClinVar as Benign. ClinVar VariationId is 158692.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.113 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIFBPNM_015634.4 linkc.1023G>A p.Gln341Gln synonymous_variant Exon 7 of 7 ENST00000361983.7 NP_056449.1
KIFBPXM_017016067.2 linkc.225G>A p.Gln75Gln synonymous_variant Exon 4 of 4 XP_016871556.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIFBPENST00000361983.7 linkc.1023G>A p.Gln341Gln synonymous_variant Exon 7 of 7 1 NM_015634.4 ENSP00000354848.4

Frequencies

GnomAD3 genomes
AF:
0.0547
AC:
8310
AN:
151916
Hom.:
753
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.190
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0218
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000574
Gnomad OTH
AF:
0.0336
GnomAD2 exomes
AF:
0.0140
AC:
3519
AN:
250868
AF XY:
0.0106
show subpopulations
Gnomad AFR exome
AF:
0.190
Gnomad AMR exome
AF:
0.00894
Gnomad ASJ exome
AF:
0.00308
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000511
Gnomad OTH exome
AF:
0.00836
GnomAD4 exome
AF:
0.00562
AC:
8217
AN:
1461392
Hom.:
698
Cov.:
32
AF XY:
0.00487
AC XY:
3540
AN XY:
727012
show subpopulations
African (AFR)
AF:
0.195
AC:
6494
AN:
33354
American (AMR)
AF:
0.00982
AC:
438
AN:
44612
Ashkenazi Jewish (ASJ)
AF:
0.00291
AC:
76
AN:
26112
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000313
AC:
27
AN:
86188
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53394
Middle Eastern (MID)
AF:
0.0125
AC:
72
AN:
5766
European-Non Finnish (NFE)
AF:
0.000268
AC:
298
AN:
1111922
Other (OTH)
AF:
0.0135
AC:
812
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
343
685
1028
1370
1713
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0549
AC:
8350
AN:
152034
Hom.:
761
Cov.:
32
AF XY:
0.0526
AC XY:
3909
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.191
AC:
7896
AN:
41424
American (AMR)
AF:
0.0217
AC:
332
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10586
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000574
AC:
39
AN:
67980
Other (OTH)
AF:
0.0333
AC:
70
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
344
687
1031
1374
1718
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0581
Hom.:
527
Bravo
AF:
0.0622
Asia WGS
AF:
0.0110
AC:
37
AN:
3478
EpiCase
AF:
0.000600
EpiControl
AF:
0.000830

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 02, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Goldberg-Shprintzen syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.1
DANN
Benign
0.46
PhyloP100
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16926021; hg19: chr10-70775329; API